About Kingston Biotechnology Research

Our Mission

At Kingston Biotechnology Research, we bridge the gap between fundamental biological discovery and therapeutic impact. Our interdisciplinary teams combine deep domain expertise in genomics, structural biology, and computational chemistry to address the most challenging problems in human health and environmental sustainability.

Founded in 2018 in Kingston, NY, KBR has grown from a five-person startup to a 100+ person research organization with four active therapeutic programs and partnerships with leading academic institutions including MIT, Stanford, and the European Bioinformatics Institute.

Our research philosophy is rooted in rigorous scientific methodology, open collaboration, and a commitment to translating discoveries into real-world outcomes. Every project begins with a clear therapeutic hypothesis and is evaluated against measurable milestones.